1 month ago
Global Companies Expand India Operations Amid Growth
Several big global companies are expanding their operations in India.
West Pharmaceutical Services sees India as a key growth market, especially for drugs like GLP-1.
Airbus has opened a new helicopter assembly line to meet growing demand.
Valeo is investing in electric car parts and cameras, aiming to triple sales by 2028.
Nestlé expects India to keep growing fast, even as some benefits from tax changes fade.
3M has seen seven straight quarters of strong growth in India.
Crown Holdings plans to spend $250 million on a new plant.
These companies are optimistic about India's future but are also cautious about competition and regulations.
West Pharmaceutical Services identifies India as a key growth market for biosimilar and GLP-1 products.
Airbus SE opens a new helicopter assembly line in India to meet civil and military demand.
Valeo SE expands manufacturing for electric powertrains and camera systems, targeting €700 million sales by 2028.
Nestlé S.A. expects double-digit growth in India despite normalizing sales-tax benefits.
3M Company reports seven consecutive quarters of double-digit growth in India.
Crown Holdings, Inc. plans a $250 million investment in a new Indian plant with long-term customer commitments.
- Who
- Global corporations including West Pharmaceutical Services, Airbus SE, Valeo SE, Nestlé S.A., 3M Company, and Crown Holdings, Inc.
- What
- Expansion and investment in India across various sectors.
- Where
- India.
- When
- During the June quarter earnings season of 2026.
- Why
- To capitalize on India's growing market potential and demand.
Optimistic Expansion
Cautious Growth
Market Potential
Optimistic Expansion
India is seen as a key growth driver with significant market potential, especially in sectors like pharmaceuticals, aerospace, automotive, and consumer goods.
Cautious Growth
While growth is evident, companies are cautious about the competitive landscape and regulatory challenges.
Key facts
- West Pharmaceutical Services
- Identified India as second-fastest-growing market, led by biosimilar and GLP-1 products.
- Airbus SE
- Opened a helicopter assembly line in India to meet civil and military demand.
- Valeo SE
- Expanding manufacturing for electric powertrains and camera systems, targeting €700 million sales by 2028.
- Nestlé S.A.
- Expects double-digit growth in India despite normalizing sales-tax benefits.
- 3M Company
- Reported seven consecutive quarters of double-digit growth in India.
- Crown Holdings, Inc.
- Plans $250 million investment in a new Indian plant with long-term customer commitments.
Quotes
West Pharmaceutical Services CEO
Chief executive of the drug-packaging company
“India is currently our second-largest geographic growth engine after China. Growth is broad-based but led by generic and biosimilar GLP-1 products, where we are participating in several newly-approved Indian programmes and will scale alongside our customers.”
thehindubusinessline.com
“We opened a new assembly line in India as helicopter demand accelerates across both civil and military markets. The facility expands our production capacity and adds India to our global assembly footprint alongside France, Germany, the US and Brazil.”
thehindubusinessline.com
Sources
Related news
Bengaluru Engineers Develop Affordable AI PC KEO
Jefferies sees 40% upside in Kalyan Jewellers shares
Nara Lokesh Lays Foundation Stone for Radisson Ongole Hotel
Joyalukkas Launches Primora Diamond Collection Worldwide
Pochampally Ikat Products to Get QR Code Authentication Tags
Vignan Institutes Welcome New Students in Grand Visakhapatnam Programme
Airbus Accelerates A400M Firefighting Efforts Amid European Wildfires
IIT Kharagpur Achieves Strong Phase I Placements 2025-26
Airbus Beats 2025 Delivery Target
Airbus Orders 6,000 A320 Fixes
